NASDAQ:STSS - US82003F2002 - Common Stock
The current stock price of STSS is 11.44 USD. In the past month the price increased by 20.18%. In the past year, price decreased by -99.56%.
Symbol | Company Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
ALC | ALCON INC | 27.14 | 40.69B | ||
COO | COOPER COS INC/THE | 18.95 | 14.67B | ||
SOLV | SOLVENTUM CORP | 11.97 | 12.62B | ||
ALGN | ALIGN TECHNOLOGY INC | 15.45 | 10.54B | ||
MMSI | MERIT MEDICAL SYSTEMS INC | 24.18 | 5.24B | ||
BLCO | BAUSCH + LOMB CORP | 35.05 | 5.21B | ||
LNTH | LANTHEUS HOLDINGS INC | 8.91 | 3.87B | ||
ICUI | ICU MEDICAL INC | 16.76 | 3.11B | ||
XRAY | DENTSPLY SIRONA INC | 8.5 | 2.90B | ||
HAE | HAEMONETICS CORP/MASS | 11.97 | 2.68B | ||
UFPT | UFP TECHNOLOGIES INC | 25.46 | 1.69B | ||
STAA | STAAR SURGICAL CO | N/A | 1.35B |
Sharps Technology, Inc. is a medical device and pharmaceutical packaging company, which engages in the development and manufacturing of innovative drug delivery systems. The company is headquartered in Melville, New York and currently employs 5 full-time employees. The company went IPO on 2022-04-14. The firm is engaged in offering patented smart-safety syringe products to the healthcare industry. The firm's smart safety syringe products, such as Securgard, Sologard, and Sharps Provensa, are ultra-low waste syringes that incorporate both passive and active safety and reuse prevention features. The company Sharps Securegard and Sologard safety syringe product lines incorporate both active and passive safety features and have been designed to address the primary administration concerns with syringe delivery systems, including accidental needlestick injuries, wasted medicine/dead space and reuse prevention. The company also offers products that are designed with specialized copolymer technology to support the prefillable syringe market segment. The company has a manufacturing facility in Hungary and is pursuing plans to expand its manufacturing capacity in the United States.
SHARPS TECHNOLOGY INC
105 Maxess Road, Ste. 124
Melville NEW YORK US
Employees: 55
Phone: 15162464000
The current stock price of STSS is 11.44 USD. The price increased by 55.65% in the last trading session.
The exchange symbol of SHARPS TECHNOLOGY INC is STSS and it is listed on the Nasdaq exchange.
STSS stock is listed on the Nasdaq exchange.
7 analysts have analysed STSS and the average price target is 22.44 USD. This implies a price increase of 96.15% is expected in the next year compared to the current price of 11.44. Check the SHARPS TECHNOLOGY INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
SHARPS TECHNOLOGY INC (STSS) has a market capitalization of 11.67M USD. This makes STSS a Nano Cap stock.
SHARPS TECHNOLOGY INC (STSS) currently has 55 employees.
The Revenue of SHARPS TECHNOLOGY INC (STSS) is expected to decline by -95.06% in the next year. Check the estimates tab for more information on the STSS EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
STSS does not pay a dividend.
SHARPS TECHNOLOGY INC (STSS) does not have a PE ratio as the earnings reported over the last twelve months were negative (-2218.66).
The outstanding short interest for SHARPS TECHNOLOGY INC (STSS) is 2.72% of its float. Check the ownership tab for more information on the STSS short interest.
ChartMill assigns a technical rating of 3 / 10 to STSS. When comparing the yearly performance of all stocks, STSS is a bad performer in the overall market: 83.61% of all stocks are doing better.
ChartMill assigns a fundamental rating of 2 / 10 to STSS. STSS scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.
Over the last trailing twelve months STSS reported a non-GAAP Earnings per Share(EPS) of -2218.66. The EPS increased by 55.59% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -54.41% | ||
ROE | -63.94% | ||
Debt/Equity | 0 |
7 analysts have analysed STSS and the average price target is 22.44 USD. This implies a price increase of 96.15% is expected in the next year compared to the current price of 11.44.
For the next year, analysts expect an EPS growth of -633.33% and a revenue growth -95.06% for STSS